CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice-Reference-Cited by-同舟云学术

CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice

Published:2014-03 Issue:1 Volume:19 Page:74-80
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Ma JinZhu,Wang HuaLei,Zheng XueXing,Xue XiangHong,Wang BeiYan,Wu HongXia,Zhang Kun,Fan ShengTao,Wang TieCheng,Li Nan,Zhao YongKun,Gao YuWei,Yang SongTao,Xia XianZhu

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference37 articles.

1. Early events in the pathogenesis of eastern equine encephalitis virus in mice;Vogel;Am J Pathol,2005

2. Viral encephalitis caused by biowarfare agents;Stienlauf;Harefuah,2002

3. Genetic and antigenic diversity among eastern equine encephalitis viruses from North, Central, and South America;Brault;Am J Trop Med Hyg,1999

4. REVIEW PAPER: pathology of animal models of alphavirus encephalitis;Steele;Vet Pathol,2010

5. Outbreak of encephalitis in man due to the eastern virus of equine encephalomyelitis;Feemster;Am J Public Health Nations Health,1938

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy;Advanced Science;2024-08-08

2. Advancements in the development of nucleic acid vaccines for syphilis prevention and control;Human Vaccines & Immunotherapeutics;2023-08

3. The main groups of adjuvants and the prospects of their use for the specific prevention of particularly dangerous and other infectious diseases;Journal of microbiology, epidemiology and immunobiology;2023-07-11

4. Microneedle‐Mediated Transcutaneous Immunization: Potential in Nucleic Acid Vaccination;Advanced Healthcare Materials;2023-05-10

5. Highly Prolonged Release of the Cancer Vaccine and Immunomodulator via a Two-Layer Biodegradable Microneedle for Prophylactic Treatment of Metastatic Cancer;Biomacromolecules;2023-02-21